Stoke Therapeutics, Inc. (STOK) — DEF 14A Filings
All DEF 14A filings from Stoke Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Stoke Therapeutics Files 2025 Proxy Statement
— Apr 22, 2025 Risk: low
Stoke Therapeutics, Inc. filed its definitive proxy statement on April 22, 2025, for its annual meeting of stockholders scheduled for June 3, 2025. The filing d -
Stoke Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 23, 2024 Risk: low
Stoke Therapeutics, Inc. (STOK) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. The 2024 Annual Meeting of Stockholders for Stoke Therapeutics
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX